Striatal dopamine receptor plasticity in neurotensin deficient mice

Lucy G. Chastain, Hongyan Qu, Chase H. Bourke, P. Michael Iuvone, Paul R. Dobner, Charles Nemeroff, Becky Kinkead

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Schizophrenia is thought to be caused, at least in part, by dysfunction in striatal dopamine neurotransmission. Both clinical studies and animal research have implicated the dopamine neuromodulator neurotensin (NT) in the pathophysiology of schizophrenia. Utilizing male mice lacking the NT gene (NT-/-), these studies examined the consequences of NT deficiency on dopaminergic tone and function, investigating (1) dopamine concentrations and dopamine receptor and transporter expression and binding in dopaminergic terminal regions, and (2) the behavioral effects of selective dopamine receptor agonists on locomotion and sensorimotor gating in adult NT-/- mice compared to wildtype (NT+/+) mice. NT-/- mice did not differ from NT+/+ mice in concentrations of dopamine or its metabolite DOPAC in any brain region examined. However, NT-/- mice showed significantly increased D1 receptor, D2 receptor, and dopamine transporter (DAT) mRNA in the caudate putamen compared to NT+/+ controls. NT-/- mice also showed elevated D2 receptor binding densities in both the caudate putamen and nucleus accumbens shell compared to NT+/+ mice. In addition, some of the behavioral effects of the D1-type receptor agonist SKF-82958 and the D2-type receptor agonist quinpirole on locomotion, startle amplitude, and prepulse inhibition were dose-dependently altered in NT-/- mice, showing altered D1-type and D2-type receptor sensitivity to stimulation by agonists in the absence of NT. The results indicate that NT deficiency alters striatal dopamine receptor expression, binding, and function. This suggests a critical role for the NT system in the maintenance of striatal DA system homeostasis and implicates NT deficiency in the etiology of dopamine-associated disorders such as schizophrenia.

Original languageEnglish
Pages (from-to)160-171
Number of pages12
JournalBehavioural Brain Research
Volume280
DOIs
StatePublished - Mar 1 2015

Fingerprint

Corpus Striatum
Neurotensin
Dopamine Receptors
Dopamine
Schizophrenia
Dopamine Plasma Membrane Transport Proteins
Putamen
Locomotion
Sensory Gating
Quinpirole
3,4-Dihydroxyphenylacetic Acid
Caudate Nucleus
Dopamine Agonists

Keywords

  • Dopamine
  • Dopamine receptor
  • Neurotensin
  • Schizophrenia
  • Striatum

ASJC Scopus subject areas

  • Behavioral Neuroscience

Cite this

Chastain, L. G., Qu, H., Bourke, C. H., Iuvone, P. M., Dobner, P. R., Nemeroff, C., & Kinkead, B. (2015). Striatal dopamine receptor plasticity in neurotensin deficient mice. Behavioural Brain Research, 280, 160-171. https://doi.org/10.1016/j.bbr.2014.11.014

Striatal dopamine receptor plasticity in neurotensin deficient mice. / Chastain, Lucy G.; Qu, Hongyan; Bourke, Chase H.; Iuvone, P. Michael; Dobner, Paul R.; Nemeroff, Charles; Kinkead, Becky.

In: Behavioural Brain Research, Vol. 280, 01.03.2015, p. 160-171.

Research output: Contribution to journalArticle

Chastain, LG, Qu, H, Bourke, CH, Iuvone, PM, Dobner, PR, Nemeroff, C & Kinkead, B 2015, 'Striatal dopamine receptor plasticity in neurotensin deficient mice', Behavioural Brain Research, vol. 280, pp. 160-171. https://doi.org/10.1016/j.bbr.2014.11.014
Chastain, Lucy G. ; Qu, Hongyan ; Bourke, Chase H. ; Iuvone, P. Michael ; Dobner, Paul R. ; Nemeroff, Charles ; Kinkead, Becky. / Striatal dopamine receptor plasticity in neurotensin deficient mice. In: Behavioural Brain Research. 2015 ; Vol. 280. pp. 160-171.
@article{a889f1c59f0e4444a7a09ae37da58431,
title = "Striatal dopamine receptor plasticity in neurotensin deficient mice",
abstract = "Schizophrenia is thought to be caused, at least in part, by dysfunction in striatal dopamine neurotransmission. Both clinical studies and animal research have implicated the dopamine neuromodulator neurotensin (NT) in the pathophysiology of schizophrenia. Utilizing male mice lacking the NT gene (NT-/-), these studies examined the consequences of NT deficiency on dopaminergic tone and function, investigating (1) dopamine concentrations and dopamine receptor and transporter expression and binding in dopaminergic terminal regions, and (2) the behavioral effects of selective dopamine receptor agonists on locomotion and sensorimotor gating in adult NT-/- mice compared to wildtype (NT+/+) mice. NT-/- mice did not differ from NT+/+ mice in concentrations of dopamine or its metabolite DOPAC in any brain region examined. However, NT-/- mice showed significantly increased D1 receptor, D2 receptor, and dopamine transporter (DAT) mRNA in the caudate putamen compared to NT+/+ controls. NT-/- mice also showed elevated D2 receptor binding densities in both the caudate putamen and nucleus accumbens shell compared to NT+/+ mice. In addition, some of the behavioral effects of the D1-type receptor agonist SKF-82958 and the D2-type receptor agonist quinpirole on locomotion, startle amplitude, and prepulse inhibition were dose-dependently altered in NT-/- mice, showing altered D1-type and D2-type receptor sensitivity to stimulation by agonists in the absence of NT. The results indicate that NT deficiency alters striatal dopamine receptor expression, binding, and function. This suggests a critical role for the NT system in the maintenance of striatal DA system homeostasis and implicates NT deficiency in the etiology of dopamine-associated disorders such as schizophrenia.",
keywords = "Dopamine, Dopamine receptor, Neurotensin, Schizophrenia, Striatum",
author = "Chastain, {Lucy G.} and Hongyan Qu and Bourke, {Chase H.} and Iuvone, {P. Michael} and Dobner, {Paul R.} and Charles Nemeroff and Becky Kinkead",
year = "2015",
month = "3",
day = "1",
doi = "10.1016/j.bbr.2014.11.014",
language = "English",
volume = "280",
pages = "160--171",
journal = "Behavioural Brain Research",
issn = "0166-4328",
publisher = "Elsevier",

}

TY - JOUR

T1 - Striatal dopamine receptor plasticity in neurotensin deficient mice

AU - Chastain, Lucy G.

AU - Qu, Hongyan

AU - Bourke, Chase H.

AU - Iuvone, P. Michael

AU - Dobner, Paul R.

AU - Nemeroff, Charles

AU - Kinkead, Becky

PY - 2015/3/1

Y1 - 2015/3/1

N2 - Schizophrenia is thought to be caused, at least in part, by dysfunction in striatal dopamine neurotransmission. Both clinical studies and animal research have implicated the dopamine neuromodulator neurotensin (NT) in the pathophysiology of schizophrenia. Utilizing male mice lacking the NT gene (NT-/-), these studies examined the consequences of NT deficiency on dopaminergic tone and function, investigating (1) dopamine concentrations and dopamine receptor and transporter expression and binding in dopaminergic terminal regions, and (2) the behavioral effects of selective dopamine receptor agonists on locomotion and sensorimotor gating in adult NT-/- mice compared to wildtype (NT+/+) mice. NT-/- mice did not differ from NT+/+ mice in concentrations of dopamine or its metabolite DOPAC in any brain region examined. However, NT-/- mice showed significantly increased D1 receptor, D2 receptor, and dopamine transporter (DAT) mRNA in the caudate putamen compared to NT+/+ controls. NT-/- mice also showed elevated D2 receptor binding densities in both the caudate putamen and nucleus accumbens shell compared to NT+/+ mice. In addition, some of the behavioral effects of the D1-type receptor agonist SKF-82958 and the D2-type receptor agonist quinpirole on locomotion, startle amplitude, and prepulse inhibition were dose-dependently altered in NT-/- mice, showing altered D1-type and D2-type receptor sensitivity to stimulation by agonists in the absence of NT. The results indicate that NT deficiency alters striatal dopamine receptor expression, binding, and function. This suggests a critical role for the NT system in the maintenance of striatal DA system homeostasis and implicates NT deficiency in the etiology of dopamine-associated disorders such as schizophrenia.

AB - Schizophrenia is thought to be caused, at least in part, by dysfunction in striatal dopamine neurotransmission. Both clinical studies and animal research have implicated the dopamine neuromodulator neurotensin (NT) in the pathophysiology of schizophrenia. Utilizing male mice lacking the NT gene (NT-/-), these studies examined the consequences of NT deficiency on dopaminergic tone and function, investigating (1) dopamine concentrations and dopamine receptor and transporter expression and binding in dopaminergic terminal regions, and (2) the behavioral effects of selective dopamine receptor agonists on locomotion and sensorimotor gating in adult NT-/- mice compared to wildtype (NT+/+) mice. NT-/- mice did not differ from NT+/+ mice in concentrations of dopamine or its metabolite DOPAC in any brain region examined. However, NT-/- mice showed significantly increased D1 receptor, D2 receptor, and dopamine transporter (DAT) mRNA in the caudate putamen compared to NT+/+ controls. NT-/- mice also showed elevated D2 receptor binding densities in both the caudate putamen and nucleus accumbens shell compared to NT+/+ mice. In addition, some of the behavioral effects of the D1-type receptor agonist SKF-82958 and the D2-type receptor agonist quinpirole on locomotion, startle amplitude, and prepulse inhibition were dose-dependently altered in NT-/- mice, showing altered D1-type and D2-type receptor sensitivity to stimulation by agonists in the absence of NT. The results indicate that NT deficiency alters striatal dopamine receptor expression, binding, and function. This suggests a critical role for the NT system in the maintenance of striatal DA system homeostasis and implicates NT deficiency in the etiology of dopamine-associated disorders such as schizophrenia.

KW - Dopamine

KW - Dopamine receptor

KW - Neurotensin

KW - Schizophrenia

KW - Striatum

UR - http://www.scopus.com/inward/record.url?scp=84919904339&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84919904339&partnerID=8YFLogxK

U2 - 10.1016/j.bbr.2014.11.014

DO - 10.1016/j.bbr.2014.11.014

M3 - Article

C2 - 25449842

AN - SCOPUS:84919904339

VL - 280

SP - 160

EP - 171

JO - Behavioural Brain Research

JF - Behavioural Brain Research

SN - 0166-4328

ER -